Case Study · Post-MortemPlant-based wellness · DTC

A $2,629 lesson in client selection

Spiritual Plants had a sharp hook, a working checkout, and 100+ creatives. It still returned 0.037× — because the brief was unwinnable before launch. This is the full autopsy, and the qualification gate it produced.

$0

Total ad spend

0.000x

Return on ad spend

0.00%

CTR — the hook worked

0

Creatives produced

Ran onMeta AdsShopify CROKlaviyo

01 · The Client

A movement, not a business

"Holy Water" was a hemp/CBD beverage enhancer from a pre-revenue founder who was, by his own account, mid-way through a $35M raise — "no fans, no product sales, but I can create a movement." I came in one layer down, subcontracted through the agency-of-record he'd hired.

That structure mattered. The person whose ad budget and approval gated everything was a founder whose real scoreboard was the raise — and I didn't fully register that until the last call.

02 · The brief that couldn't win

I was told to sell CBD to people who don't buy CBD

The founder mandated targeting people who had never bought CBD — explicitly the hardest audience — with polarized, "convince-the-skeptic" messaging instead of "let ready buyers buy." The agency and I both pushed back. We were overruled.

"When you ask me to convince non-buyers to buy instead of allowing people to buy, this will probably bring zero — and if we're lucky, 0.25 ROAS by the end of the month."

— my recorded forecast, before launch. Actual result: 0.037.

The differentiating angle — a political "permission" concept — was an unvalidated idea the founder liked. Meta later rejected it outright, so only the compliant fallback ever ran.

03 · What we shipped

The work was there. The approvals weren't.

100+ single-image concepts, six Klaviyo sequences, and a rebuilt Shopify product page. Then roughly a month passed with nothing running — the founder rejected creative after creative — and the one angle that was supposed to differentiate got banned by the platform.

0

Creatives produced · nearly all rejected before launch

04 · The numbers

High CTR. Two sales.

The compliant creative actually performed at the top: an 8.09% CTR on the main sales campaign. People clicked, and 85 of them added to cart. Then purchase intent evaporated — because curiosity from a non-buyer audience doesn't pay $100 for a CBD product it's skeptical of. Checkout was tested and working; this was demand, not mechanics.

84,322
Impressions
1,645
Clicks (8.09% CTR)
85
Add to cart
2
Purchases

$2,629 spent · 2 purchases · 0.037× ROAS · $1,166 cost per sale. The follow-up campaign was built and never spent a dollar.

05 · Five hypotheses

Why did it fail?

I tested five competing explanations against the full record — transcripts, the WhatsApp history, and the live ad account. Here's how each held up.

H1A broken on-site funnel

Refuted

Checkout was tested working; the drop-off was at purchase intent, not mechanics. The craft wasn't the problem.

Ownership · Not the cause

H2An under-funded, abandoned test

Partial

True that it never got a fair run — but because the founder rejected every creative for ~a month, then never funded the follow-up. Not under-investment by the agency.

Ownership · Client-driven

H3The founder optimized for a raise, not ROAS

Confirmed

A $35M raise 'by May 17', 'create a movement', 'I don't care after this launch.' Ads were proof-for-bankers, not a profit engine.

Ownership · Client-driven

H4The differentiator was un-runnable on Meta

Confirmed

The political angle was rejected outright — but it was unvalidated, and the channels where it's allowed reach an audience that doesn't buy CBD. Channel was never the fix.

Ownership · Client + platform

H5Wrong audience, by founder mandate

Confirmed

Targeting explicit non-CBD-buyers with polarized messaging — over the agency's documented objection — is paying to do the hardest thing in marketing. This is the central cause.

Ownership · Client-driven

06 · The verdict

Was this my ICP? No.

My offer is Meta Ads + CRO for a business with a validated, sellable offer aimed at a reachable buying audience. Spiritual Plants broke nearly every one of those at once — pre-revenue, raise-driven, an audience chosen because they don't buy the product, a founder who overruled expertise and blocked the work, and a path to success that lived outside the channels I run. The honest split:

85% client-fit / founder / market
15% mine

And the 15% that's mine isn't craft — it's qualification and exit discipline.

What worked

  • Forecast the outcome in writing, before launch.
  • Pushed back — with the agency — on the doomed targeting and message.
  • Shipped a working funnel and an 8% CTR on the compliant creative.
  • 100+ concepts, with Meta-compliance discipline that avoided account-level violations.

What I'd do differently

  • Qualify harder up front — the red flags were visible by week one.
  • Walk, or switch to a flat creative fee, the moment the brief turned unwinnable.
  • Surface the raise-vs-sales misalignment in month one, not on the last call.
  • Own the go/no-go regardless of who holds the contract.

07 · The deliverable

The qualification gate

Every failure should pay for itself. This one bought a pre-engagement screen. More than two "no"s and I decline, or re-scope to a non-performance deliverable. Spiritual Plants failed six of seven.

  • A validated, already-selling offer — not just a founder conviction?
  • Is the founder's real KPI sales/ROAS — not a raise, press, or a 'movement'?
  • Is the target a real buyer pool — not an audience chosen because they don't buy?
  • Will the founder defer to expertise on targeting and messaging?
  • A funded budget for a fair test, with payment actually in place day one?
  • Is success achievable inside Meta + CRO — not secretly dependent on PR/other channels?
  • Is the authority structure clear enough that my 'no' is heard?

I qualify harder now

If you've got a validated offer and a real audience that already buys, Meta + CRO can scale it. If you're not sure yet — that's exactly the conversation to have first.

Book a Revenue Diagnostic

Internal post-mortem · figures from the live Meta ad account, transcripts, and chat history.

Pareto 13 Ltd, registered in England & Wales, company no. 15014377. VAT no. GB 525 4202 23.
Registered with the UK Information Commissioner's Office for data protection, no. ZC241334.
© 2026 Pareto 13 Ltd. All rights reserved.